Мақаланы E-mail арқылы жіберу Contrast Agents Based on Iron Oxide Nanoparticles for Clinical Magnetic Resonance Imaging
- Авторлар: Abakumov M.1,2, Ternovoi S.3,4, Mazhuga A.2,5,6, Chekhonin V.1, Demikhov E.7, Pistrak A.7, Konstantinov M.7, Dmitriev D.7, Myshkinis B.8
-
Мекемелер:
- N. I. Pirogov Russian Research Medical University, Ministry of Health of the Russian Federation
- Biomedical Nanomaterials Laboratory, National University of Science and Technology MISIS
- National Medical Research Center for Cardiology, Ministry of Health of the Russian Federation
- I. M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of the Russian Federation
- Faculty of Chemistry, M. V. Lomonosov Moscow State University
- D. I. Mendeleev Russian Chemical Technological University
- P. N. Lebedev Physical Institute, Russian Academy of Sciences
- Gelpik Company
- Шығарылым: Том 167, № 2 (2019)
- Беттер: 272-274
- Бөлім: Biotechnologies
- URL: https://journals.rcsi.science/0007-4888/article/view/241637
- DOI: https://doi.org/10.1007/s10517-019-04507-y
- ID: 241637
Дәйексөз келтіру
Ашық рұқсат
Рұқсат берілді
Тек жазылушылар үшін
Аннотация
Magnetic resonance imaging (MRI) is one of the most perspective methods of noninvasive visualization in medicine, and use of contrast agents significantly its potentialities extends. Iron oxide nanoparticles are promising contrast agents, but in fact all the data on their efficiency were obtained in high-field tomographs for experimental animals. We studied the possibility of using magnetic nanoparticles for MRI visualization of rat brain glioblastoma at the most common clinical field 1.5 T The data indicate the efficiency of iron oxide magnetic nanoparticles as contrast agents for 1.5 T MR tomographs.
Авторлар туралы
M. Abakumov
N. I. Pirogov Russian Research Medical University, Ministry of Health of the Russian Federation; Biomedical Nanomaterials Laboratory, National University of Science and Technology MISIS
Хат алмасуға жауапты Автор.
Email: abakumov1988@gmail.com
Ресей, Moscow; Moscow
S. Ternovoi
National Medical Research Center for Cardiology, Ministry of Health of the Russian Federation; I. M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of the Russian Federation
Email: abakumov1988@gmail.com
Ресей, Moscow; Moscow
A. Mazhuga
Biomedical Nanomaterials Laboratory, National University of Science and Technology MISIS; Faculty of Chemistry, M. V. Lomonosov Moscow State University; D. I. Mendeleev Russian Chemical Technological University
Email: abakumov1988@gmail.com
Ресей, Moscow; Moscow; Moscow
V. Chekhonin
N. I. Pirogov Russian Research Medical University, Ministry of Health of the Russian Federation
Email: abakumov1988@gmail.com
Ресей, Moscow
E. Demikhov
P. N. Lebedev Physical Institute, Russian Academy of Sciences
Email: abakumov1988@gmail.com
Ресей, Moskva
A. Pistrak
P. N. Lebedev Physical Institute, Russian Academy of Sciences
Email: abakumov1988@gmail.com
Ресей, Moskva
M. Konstantinov
P. N. Lebedev Physical Institute, Russian Academy of Sciences
Email: abakumov1988@gmail.com
Ресей, Moskva
D. Dmitriev
P. N. Lebedev Physical Institute, Russian Academy of Sciences
Email: abakumov1988@gmail.com
Ресей, Moskva
B. Myshkinis
Gelpik Company
Email: abakumov1988@gmail.com
Ресей, Moscow
